Characterization and comparative genomic analysis of a novel bacteriophage, SFP10, simultaneously inhibiting both Salmonella enterica and Escherichia coli O157:H7

Applied and Environmental Microbiology

Volumn 78, Issue 1, 2012, Pages 58-69

  Park, Minjung ^a   Lee, Ju Hoon ^b   Shin, Hakdong ^a   Kim, Minsik ^a   Choi, Jeongjoon ^a   Kang, Dong Hyun ^a   Heu, Sunggi ^c   Ryu, Sangryeol ^a  

^a Seoul National University   (South Korea)

^b CHA University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION CONSTANT; BURST SIZE; COMPARATIVE ANALYSIS; COMPARATIVE GENOMIC; DIFFERENTIAL DEVELOPMENT; DOUBLE STRANDED DNA; E.COLI O157:H7; ESCHERICHIA COLI O157:H7; FOOD-BORNE PATHOGENS; GENOME SEQUENCES; GROWTH ANALYSIS; HOST-SPECIFICITY; IN-VITRO; O-ANTIGEN; S. TYPHIMURIUM; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM; SEQUENCE IDENTITY;

ADSORPTION; BACTERIOPHAGES; GENES; SALMONELLA;

ESCHERICHIA COLI;

VIRUS DNA;

ADSORPTION; ANTIGEN; BACTERIOPHAGE; COLIFORM BACTERIUM; COMPARATIVE STUDY; EMERGENCE; HOST SPECIFICITY; INFECTIVITY; INHIBITION; PATHOGEN;

ARTICLE; BACTERIOPHAGE; COMPARATIVE STUDY; DNA SEQUENCE; ESCHERICHIA COLI O157; FOOD CONTROL; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PHYSIOLOGY; SALMONELLA ENTERICA; VIROLOGY; VIRUS GENOME;

BASE SEQUENCE; DNA, VIRAL; ESCHERICHIA COLI O157; FOOD MICROBIOLOGY; GENOME, VIRAL; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; MYOVIRIDAE; PHYLOGENY; SALMONELLA ENTERICA; SEQUENCE ANALYSIS, DNA;

ESCHERICHIA COLI; MYOVIRIDAE; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM; SHIGELLA;

EID: 84862909103     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.06231-11     Document Type: Article

References (74)

1. Altermann E, Klaenhammer TR. 2003. GAMOLA: a new local solution for sequence annotation and analyzing draft and finished prokaryotic genomes. OMICS 7:161-169.
2. Anany H, et al. 2011. A Shigella boydii bacteriophage which resembles Salmonella phage ViI. Virol. J. 8:242.
3. Barbara G, et al. 2000. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment. Pharmacol. Ther. 14:1127-1131.
4. Baxa U, et al. 1996. Interactions of phage P22 tails with their cellular receptor, Salmonella O-antigen polysaccharide. Biophys. J. 71:2040-2048.
5. Besemer J, Lomsadze A, Borodovsky M. 2001. GeneMarkS: a selftraining method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res. 29:2607-2618.
6. Bielke L, Higgins S, Donoghue A, Donoghue D, Hargis BM. 2007. Salmonella host range of bacteriophages that infect multiple genera. Poult. Sci. 86:2536-2540.
7. Bigwood T, Hudson JA, Billington C, Carey-Smith GV, Heinemann JA. 2008. Phage inactivation of foodborne pathogens on cooked and raw meat. Food Microbiol. 25:400-406.
8. Borie C, et al. 2008. Bacteriophage treatment reduces Salmonella colonization of infected chickens. Avian Dis. 52:64-67.
9. Bruttin A, Brussow H. 2005. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49:2874-2878.
10. Cairns BJ, Payne RJH. 2008. Bacteriophage therapy and the mutant selection window. Antimicrob. Agents Chemother. 52:4344-4350.
11. Calendar R. 2006. The bacteriophages, 2nd ed. Oxford University Press, New York, NY.
12. Campbell A. 2003. The future of bacteriophage biology. Nat. Rev. Genet. 4:471-477.
13. Carver T, et al. 2008. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24: 2672-2676.
14. Chang H-C, et al. 2005. Isolation and characterization of novel giant Stenotrophomonas maltophilia phage ΦSMA5. Appl. Environ. Microbiol. 71:1387-1393.
15. R cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.
16. Coffey B, Mills S, Coffey A, McAuliffe O, Ross RP. 2010. Phage and their lysins as biocontrol agents for food safety applications. Annu. Rev. Food Sci. Technol. 1:449-468.
17. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
18. De Lappe N, Doran G, O'Connor J, O'Hare C, Cormican M. 2009. Characterization of bacteriophages used in the Salmonella enterica serovar Enteritidis phage-typing scheme. J. Med. Microbiol. 58:86-93.
19. Erickson M, et al. 2009. Competition among isolates of Salmonella enterica ssp. enterica serovar Typhimurium: role of prophage/phage in archived cultures. FEMS Microbiol. Lett. 294:37-44.
20. Fauquet C, Mayo MA, Maniloff J, Desselberger U, Ball LA (ed). 2005. Virus taxonomy. Eighth report of the International Committee on the Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA.
21. Feng P, Fields PI, Swaminathan B, Whittam TS. 1996. Characterization of nonmotile variants of Escherichia coli O157 and other serotypes by using an antiflagellin monoclonal antibody. J. Clin. Microbiol. 34:2856-2859.
22. Foschino R, Perrone F, Galli A. 1995. Characterization of two virulent Lactobacillus fermentum bacteriophages isolated from sour dough. J. Appl. Microbiol. 79:677-683.
23. Frank AC, Lobry JR. 2000. Oriloc: prediction of replication boundaries in unannotated bacterial chromosomes. Bioinformatics 16:560-561.
24. Goodridge L, Gallaccio A, Griffiths MW. 2003. Morphological, host range, and genetic characterization of two coliphages. Appl. Environ. Microbiol. 69:5364-5371.
25. Goodridge LD. 2010. Designing phage therapeutics. Curr. Pharm. Biotechnol. 11:15-27.
26. Hayashi K, et al. 2006. Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol. Syst. Biol. 2:2006.0007.
27. Hendrix RW. 2003. Bacteriophage genomics. Curr. Opin. Microbiol. 6:506-511.
28. Ho TD, Slauch JM. 2001. OmpC is the receptor for Gifsy-1 and Gifsy-2 bacteriophages of Salmonella. J. Bacteriol. 183:1495-1498.
29. Hong J, et al. 2008. Identification of host receptor and receptor-binding module of a newly sequenced T5-like phage EPS7. FEMS Microbiol. Lett. 289:202-209.
30. Hyman P, Abedon ST. 2010. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 70:217-248.
31. Jensen EC, et al. 1998. Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Appl. Environ. Microbiol. 64:575-580.
32. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
33. Karmali MA, Steele BT, Petric M, Lim C. 1983. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 321:619-620.
34. Khan MA, Satoh H, Katayama H, Kurisu F, Mino T. 2002. Bacteriophages isolated from activated sludge processes and their polyvalency. Water Res. 36:3364-3370.
35. Kim M, Ryu S. 2011. Characterization of a T5-like coliphage SPC35 and differential development of resistance to SPC35 in Salmonella Typhimurium and Escherichia coli. Appl. Environ. Microbiol. 77:2042-2050.
36. Kropinski AM. 2009. Measurement of the rate of attachment of bacteriophage to cells, p. 151-155. In Clokie MRJ and Kropinski AM(ed), Bacteriophages: methods and protocols, vol. 1. Isolation, characterization, and interactions. Humana Press, New York, NY.
37. Kumar S, Nei M, Dudley J, Tamura K. 2008. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform. 9:299-306.
38. Kurtz S, et al. 2004. Versatile and open software for comparing large genomes. Genome Biol. 5:R12.
39. Landstrom J, et al. 2008. Interaction of a Salmonella enteritidis O-antigen octasaccharide with the phage P22 tailspike protein byNMRspectroscopy and docking studies. Glycoconj. J. 25:137-143.
40. Larkin MA, et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
41. Li X, Heyer W-D. 2008. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 18:99-113.
42. Liao WC, et al. 2011. T4-like genome organization of the Escherichia coli O157:H7 lytic phage AR1. J. Virol. 85:6567-6578.
43. Mahichi F, Synnott AJ, Yamamichi K, Osada T, Tanji Y. 2009. Sitespecific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity. FEMS Microbiol. Lett. 295:211-217.
44. McClelland M, et al. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.
45. Mead PS, Griffin PM. 1998. Escherichia coli O157:H7. Lancet 352: 1207-1212.
46. Mead PS, et al. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
47. Mizoguchi K, et al. 2003. Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl. Environ. Microbiol. 69:170-176.
48. Murray PR, Baron EJ. 2007. Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
49. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
50. O'Flaherty S, Ross RP, Coffey A. 2009. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol. Rev. 33:801-819.
51. O'Flaherty S, et al. 2005. Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl. Environ. Microbiol. 71:1836-1842.
52. O'Flynn G, Ross RP, Fitzgerald GF, Coffey A. 2004. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157: H7. Appl. Environ. Microbiol. 70:3417-3424.
53. Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ. 2008. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 104:1-13.
54. Perry LL, et al. 2009. Sequence analysis of Escherichia coli O157:H7 bacteriophage ΦV10 and identification of a phage-encoded immunity protein that modifies the O157 antigen. FEMS Microbiol. Lett. 292: 182-186.
55. Petty NK, Foulds IJ, Pradel E, Ewbank JJ, Salmond GPC. 2006. A generalized transducing phageΦIF3 for the genomically sequenced Serratia marcescens strain Db11: a tool for functional genomics of an opportunistic human pathogen. Microbiology 152:1701-1708.
56. Pickard D, et al. 2008. Molecular characterization of the Salmonella enterica serovar Typhi Vi-typing bacteriophage E1. J. Bacteriol. 190: 2580-2587.
57. Pickard D, et al. 2010. A conserved acetyl esterase domain targets diverse bacteriophages to the Vi capsular receptor of Salmonella enterica serovar Typhi. J. Bacteriol. 192:5746-5754.
58. Poppe C, et al. 1998. Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Can. Vet. J. 39:559-565.
59. Raya RR, et al. 2011. Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts. Bacteriophage 1:15-24.
60. Raya RR, et al. 2006. Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep. Appl. Environ. Microbiol. 72: 6405-6410.
61. Samuel ADT, et al. 1999. Flagellar determinants of bacterial sensitivity to χ-phage. Proc. Natl. Acad. Sci. U. S. A. 96:9863-9866.
62. Santos TMA, Bicalho RC. 2011. Complete genome sequence of vB_EcoM_ECO1230-10: a coliphage with therapeutic potential for bovine metritis. Vet. Microbiol. 148:267-275.
63. Schade SZ, Adler J, Ris H. 1967. How bacteriophage χ attacks motile bacteria. J. Virol. 1:599-609.
64. Sharma M, Patel JR, Conway WS, Ferguson S, Sulakvelidze A. 2009. Effectiveness of bacteriophages in reducing Escherichia coli O157:H7 on fresh-cut cantaloupes and lettuces. J. Food Prot. 72:1481-1485.
65. Soncini FC, Vescovi EG, Groisman EA. 1995. Transcriptional autoregulation of the Salmonella typhimurium phoPQ operon. J. Bacteriol. 177: 4364-4371.
66. Sulakvelidze A, Alavidze Z, Morris JG, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
67. Tanji Y, et al. 2004. Toward rational control of Escherichia coli O157:H7 by a phage cocktail. Appl. Microbiol. Biotechnol. 64:270-274.
68. Tatusov RL, et al. 2003. The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4:41.
69. Wall SK, Zhang J, Rostagno MH, Ebner PD. 2010. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl. Environ. Microbiol. 76:48-53.
70. Walter M, et al. 2008. Structure of the receptor-binding protein of bacteriophage Det7: a podoviral tail spike in a myovirus. J. Virol. 82: 2265-2273.
71. Wilcox SA, Toder R, Foster JW. 1996. Rapid isolation of recombinant lambda phageDNAfor use in fluorescence in situ hybridization. Chromosome Res. 4:397-398.
72. Yu SL, Ko KL, Chen CS, Chang YC, Syu WJ. 2000. Characterization of the distal tail fiber locus and determination of the receptor for phage AR1, which specifically infects Escherichia coli O157:H7. J. Bacteriol. 182: 5962-5968.
73. Zdobnov EM, Apweiler R. 2001. InterProScan-an integration platform for the signature-recognition methods in InterPro. Bioinformatics 17: 847-848.
74. Zhang X, Kelly SM, Bollen WS, Curtiss R, III. 1997. Characterization and immunogenicity of Salmonella typhimurium SL1344 and UK-1 Δcrp and Δcdt deletion mutants. Infect. Immun. 65:5381-5387.